A detailed history of Congress Wealth Management LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Congress Wealth Management LLC holds 199,920 shares of PLRX stock, worth $345,861. This represents 0.0% of its overall portfolio holdings.

Number of Shares
199,920
Previous 422,311 52.66%
Holding current value
$345,861
Previous $570,000 59.47%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

SELL
$1.16 - $1.69 $257,973 - $375,840
-222,391 Reduced 52.66%
199,920 $231,000
Q1 2025

May 14, 2025

BUY
$1.35 - $13.53 $570,119 - $5.71 Million
422,311 New
422,311 $570,000

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $84.2M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Congress Wealth Management LLC Portfolio

Follow Congress Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Wealth Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Congress Wealth Management LLC with notifications on news.